Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-30 Hansen Gwenn Chief Scientific Officer Sale −2,007 $12.04 $24K 39,601
2024-04-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,206 22,448
2024-04-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −2,000 16,000
2024-04-30 Ring Christine Chief Legal Officer Option exercise +1,924 19,351
2024-04-30 Ring Christine Chief Legal Officer Option exercise +2,000 21,351
2024-04-30 Ring Christine Chief Legal Officer Sale −1,513 $12.04 $18K 19,838
2024-04-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −1,924 13,469
2024-04-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −2,000 16,000
2024-02-16 van Houte Hans Chief Financial Officer Sale 10b5-1 −6,812 $10.02 $68K 68,333
2024-02-13 van Houte Hans Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2024-02-13 van Houte Hans Chief Financial Officer Grant or award · Restricted Stock Units +45,000 45,000
2024-02-13 Ring Christine Chief Legal Officer Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2024-02-13 Ring Christine Chief Legal Officer Grant or award · Restricted Stock Units +45,000 45,000
2024-02-13 Hansen Gwenn Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2024-02-13 Hansen Gwenn Chief Scientific Officer Grant or award · Restricted Stock Units +45,000 45,000
2024-02-13 SANDS ARTHUR T President, CEO Grant or award · Employee Stock Option (right to buy) +800,000 800,000
2024-01-30 van Houte Hans Chief Financial Officer Option exercise +2,886 74,816
2024-01-30 van Houte Hans Chief Financial Officer Option exercise +2,000 76,816
2024-01-30 van Houte Hans Chief Financial Officer Sale −1,671 $7.99 $13K 75,145
2024-01-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 23,089

Page 22 of 32 · 632 trades